Hemosol (HML-T) Stock Predictions - Stockchase
WATCH LIST
78
Hemosol (HML-T)

ON STOCKCHASE SINCE Oct 2000

Blood replacement/Major owner is MDS, so buy them instead.

biotechnology/pharmaceutical

Hemosol

HML-T

0 watching          
Join the Discussion

Hemosol (HML-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about HML-T



  • All
  • Filtered
Signal Opinion Expert
DON'T BUY
Hemosol(HML-T) 

August 9, 2005

This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bill Carrigan

Technical , Getting Technical In...

Price Price
$1.500
Owned Owned
Unknown

DON'T BUY
Hemosol(HML-T) 

June 13, 2005

Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$1.750
Owned Owned
No

VAGUE
Hemosol(HML-T) 

February 9, 2004

Speculative future.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Speculative future.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Sprung

President, Sprung Investment Ma...

Price Price
$1.580
Owned Owned
Unknown

BUY
Hemosol(HML-T) 

January 28, 2004

It will expire again, company has run out of money many times. Take money out, while money is on the table.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
It will expire again, company has run out of money many times. Take money out, while money is on the table.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$1.620
Owned Owned
Unknown

SELL
Hemosol(HML-T) 

January 26, 2004

Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Andrew McCreath

Senior Por, Sentry Select Capita...

Price Price
$1.560
Owned Owned
No

DON'T BUY
Hemosol(HML-T) 

December 15, 2003

Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Gavin Graham

Trustee, Pointbreak ETFs...

Price Price
$1.580
Owned Owned
No

DON'T BUY
Hemosol(HML-T) 

December 8, 2003

Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$1.700
Owned Owned
No

DON'T BUY
Hemosol(HML-T) 

December 8, 2003

A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Sinkins, C

Senior Por, Sentry Select Capita...

Price Price
$1.700
Owned Owned
Unknown

DON'T BUY
Hemosol(HML-T) 

September 5, 2003

Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Lou Schizas

Business E, Market Call...

Price Price
$0.870
Owned Owned
Unknown

DON'T BUY
Hemosol(HML-T) 

March 31, 2003

Very speculative. FDA trials didn't go well.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Very speculative. FDA trials didn't go well.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Sinkins, C

Senior Por, Sentry Select Capita...

Price Price
$0.720
Owned Owned
Unknown

DON'T BUY
Hemosol(HML-T) 

March 17, 2003

A lot of problems. May not survive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A lot of problems. May not survive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Glenn Paradis,

Vice Presi, Aegon Capital Manage...

Price Price
$0.620
Owned Owned
Unknown

DON'T BUY
Hemosol(HML-T) 

January 14, 2003

A long way from being a mature company with mature products. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A long way from being a mature company with mature products. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
David Baskin

President, Baskin Wealth Manage...

Price Price
$2.890
Owned Owned
Unknown

DON'T BUY
Hemosol(HML-T) 

January 14, 2003

Never seems to get it together.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Never seems to get it together.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$2.890
Owned Owned
Unknown

DON'T BUY
Hemosol(HML-T) 

December 5, 2002

Worst is behind them. Would prefer owning through MDS.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Worst is behind them. Would prefer owning through MDS.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Zechner

Chairman, J. Zechner & Assoc...

Price Price
$2.500
Owned Owned
Unknown

WEAK BUY
Hemosol(HML-T) 

November 7, 2002

OK for a long term hold. Buy on weakness.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
OK for a long term hold. Buy on weakness.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Campbell

President, Campbell and Lee Inv...

Price Price
$1.900
Owned Owned
Unknown

Showing 1 to 15 of 78 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days